Literature DB >> 15857984

Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.

Stefan Kunz1, Jillian M Rojek, Mar Perez, Christina F Spiropoulou, Michael B A Oldstone.   

Abstract

The cellular receptor for the Old World arenaviruses Lassa fever virus (LFV) and lymphocytic choriomeningitis virus (LCMV) has recently been identified as alpha-dystroglycan (alpha-DG), a cell surface receptor that provides a molecular link between the extracellular matrix and the actin-based cytoskeleton. In the present study, we show that LFV binds to alpha-DG with high affinity in the low-nanomolar range. Recombinant vesicular stomatitis virus pseudotyped with LFV glycoprotein (GP) adopted the receptor binding characteristics of LFV and depended on alpha-DG for infection of cells. Mapping of the binding site of LFV on alpha-DG revealed that LFV binding required the same domains of alpha-DG that are involved in the binding of LCMV. Further, LFV was found to efficiently compete with laminin alpha1 and alpha2 chains for alpha-DG binding. Together with our previous studies on receptor binding of the prototypic immunosuppressive LCMV isolate LCMV clone 13, these findings indicate a high degree of conservation in the receptor binding characteristics between the highly human-pathogenic LFV and murine-immunosuppressive LCMV isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857984      PMCID: PMC1091707          DOI: 10.1128/JVI.79.10.5979-5987.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.

Authors:  J F Talts; Z Andac; W Göhring; A Brancaccio; R Timpl
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

Authors:  O Lenz; J ter Meulen; H D Klenk; N G Seidah; W Garten
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

3.  N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry.

Authors:  M Perez; M Watanabe; M A Whitt; J C de la Torre
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 4.  Viral hemorrhagic fever hazards for travelers in Africa.

Authors:  M Isaäcson
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

5.  Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics.

Authors:  S C Smelt; P Borrow; S Kunz; W Cao; A Tishon; H Lewicki; K P Campbell; M B Oldstone
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization.

Authors:  M D Henry; J S Satz; C Brakebusch; M Costell; E Gustafsson; R Fässler; K P Campbell
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

7.  A stoichiometric complex of neurexins and dystroglycan in brain.

Authors:  S Sugita; F Saito; J Tang; J Satz; K Campbell; T C Südhof
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

8.  Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.

Authors:  N Sevilla; S Kunz; A Holz; H Lewicki; D Homann; H Yamada; K P Campbell; J C de La Torre; M B Oldstone
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

9.  Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.

Authors:  M James; A Nuttall; J L Ilsley; K Ottersbach; J M Tinsley; M Sudol; S J Winder
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

10.  Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

Authors:  S Kunz; N Sevilla; D B McGavern; K P Campbell; M B Oldstone
Journal:  J Cell Biol       Date:  2001-10-15       Impact factor: 10.539

View more
  59 in total

1.  Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Authors:  Brian M Sullivan; Sébastien F Emonet; Megan J Welch; Andrew M Lee; Kevin P Campbell; Juan C de la Torre; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

2.  Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP.

Authors:  Magali E Droniou-Bonzom; Therese Reignier; Jill E Oldenburg; Alex U Cox; Colin M Exline; Jessica Y Rathbun; Paula M Cannon
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 3.  Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response.

Authors:  Michael B A Oldstone; Kevin P Campbell
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

4.  Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell.

Authors:  Jillian M Rojek; Kevin P Campbell; Michael B A Oldstone; Stefan Kunz
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

5.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Sodium hydrogen exchangers contribute to arenavirus cell entry.

Authors:  Masaharu Iwasaki; Nhi Ngo; Juan C de la Torre
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

7.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

8.  Molecular Mechanism for LAMP1 Recognition by Lassa Virus.

Authors:  Hadas Cohen-Dvashi; Nadav Cohen; Hadar Israeli; Ron Diskin
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

9.  Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus.

Authors:  Hadas Cohen-Dvashi; Hadar Israeli; Orly Shani; Aliza Katz; Ron Diskin
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

Review 10.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.